Tortoise Investment Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-170
| Closed | -$44.6K | – | 1471 |
|
|
2025
Q3 | $44.6K | Buy |
170
+4
| +2% | +$972 | ﹤0.01% | 410 |
|
|
2025
Q2 | $36.3K | Buy |
166
+4
| +2% | +$855 | ﹤0.01% | 425 |
|
|
2025
Q1 | $36.3K | Hold |
162
| – | – | ﹤0.01% | 416 |
|
|
2024
Q4 | $53.1K | Hold |
162
| – | – | 0.01% | 410 |
|
|
2024
Q3 | $48.6K | Hold |
162
| – | – | 0.01% | 410 |
|
|
2024
Q2 | $53.4K | Hold |
162
| – | – | 0.01% | 380 |
|
|
2024
Q1 | $64.1K | Hold |
162
| – | – | 0.01% | 351 |
|
|
2023
Q4 | $57K | Hold |
162
| – | – | 0.01% | 342 |
|
|
2023
Q3 | $60.8K | Hold |
162
| – | – | 0.01% | 321 |
|
|
2023
Q2 | $62K | Hold |
162
| – | – | 0.01% | 325 |
|
|
2023
Q1 | $56.1K | Hold |
162
| – | – | 0.01% | 324 |
|
|
2022
Q4 | $38.1K | Hold |
162
| – | – | 0.01% | 358 |
|
|
2022
Q3 | $40K | Sell |
162
-1
| -0.6% | -$305 | 0.01% | 340 |
|
|
2022
Q2 | $49K | Hold |
163
| – | – | 0.01% | 308 |
|
|
2022
Q1 | $67K | Sell |
163
-3
| -2% | -$1.17K | 0.01% | 276 |
|
|
2021
Q4 | $78K | Sell |
166
-18
| -10% | -$7.75K | 0.01% | 240 |
|
|
2021
Q3 | $78K | Sell |
184
-7
| -4% | -$2.95K | 0.02% | 224 |
|
|
2021
Q2 | $69K | Sell |
191
-9
| -5% | -$2.97K | 0.01% | 234 |
|
|
2021
Q1 | $56K | Hold |
200
| – | – | 0.01% | 247 |
|
|
2020
Q4 | $57K | Sell |
200
-40
| -17% | -$11.2K | 0.01% | 230 |
|
|
2020
Q3 | $66K | Sell |
240
-19
| -7% | -$5.03K | 0.02% | 208 |
|
|
2020
Q2 | $59K | Hold |
259
| – | – | 0.02% | 208 |
|
|
2020
Q1 | $39K | Hold |
259
| – | – | 0.01% | 245 |
|
|
2019
Q4 | $39K | Hold |
259
| – | – | 0.01% | 260 |
|
|
2019
Q3 | $37K | Sell |
259
-6
| -2% | -$826 | 0.01% | 264 |
|
|
2019
Q2 | $33K | Hold |
265
| – | – | 0.01% | 287 |
|
|
2019
Q1 | $29K | Hold |
265
| – | – | 0.01% | 296 |
|
|
2018
Q4 | $26K | Hold |
265
| – | – | 0.01% | 293 |
|
|
2018
Q3 | $33K | Hold |
265
| – | – | 0.01% | 279 |
|
|
2018
Q2 | $26K | Hold |
265
| – | – | 0.01% | 307 |
|
|
2018
Q1 | $23K | Hold |
265
| – | – | 0.01% | 312 |
|
|
2017
Q4 | $26K | Hold |
265
| – | – | 0.01% | 299 |
|
|
2017
Q3 | $26K | Hold |
265
| – | – | 0.01% | 283 |
|
|
2017
Q2 | $25K | Hold |
265
| – | – | 0.01% | 272 |
|
|
2017
Q1 | $22K | Buy |
265
+6
| +2% | +$502 | 0.01% | 268 |
|
|
2016
Q4 | $22K | Hold |
259
| – | – | 0.01% | 263 |
|
|
2016
Q3 | $19K | Hold |
259
| – | – | 0.01% | 258 |
|
|
2016
Q2 | $20K | Buy |
+259
| New | +$18.8K | 0.01% | 258 |
|
Other funds holding WST
GIM
Tortoise Investment Management's WST Position: Q4 2025 in Review
Tortoise Investment Management sold out of West Pharmaceutical (WST) in Q4 2025, closing a stake of 170 shares — an estimated $44.6K sold.
Tortoise Investment Management first reported a position in WST in Q2 2016 and held it in 38 quarters. The position peaked at $78K in Q4 2021. 804 funds tracked by Wall St. Rank hold WST as of Q4 2025.
- Tortoise Investment Management reported no remaining West Pharmaceutical position as of Q4 2025 after selling out during the quarter.
- Tortoise Investment Management sold 170 West Pharmaceutical shares in Q4 2025, an estimated $44.6K.
- Tortoise Investment Management first reported a position in West Pharmaceutical in Q2 2016 and held it in 38 quarters.
- Tortoise Investment Management's West Pharmaceutical position peaked at $78K in Q4 2021.
- 804 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2025.
Based on Tortoise Investment Management's 13F filing for Q4 2025, filed 6 Feb 2026.